<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High prolactin (PRL) levels seem to be associated with active <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) during pregnancy </plain></SENT>
<SENT sid="1" pm="."><plain>However, the association of activity, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), and pregnancy outcome has not been analyzed </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to analyze the association among SLE activity, LA, and maternal-fetal outcome </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 15 pregnant SLE patients (ACR criteria), 4 of them with associated <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS), and 9 healthy pregnant women </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were evaluated monthly with the following determinations: (a) SLE activity using modified-systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> activity measurement (m-SLAM), (b) LA, and (c) PRL serum levels </plain></SENT>
<SENT sid="5" pm="."><plain>Healthy controls were evaluated each trimester </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0728731" disease_type="Disease or Syndrome" abbrv="">Prematurity</z:e>, fetal loss, <z:hpo ids='HP_0001518'>low birth weight</z:hpo>, and <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> were evaluated </plain></SENT>
<SENT sid="7" pm="."><plain>Chi-square test, Fisher's exact test, Student's t-test, Pearson correlation, and ANOVA were performed </plain></SENT>
<SENT sid="8" pm="."><plain>The mean age of SLE patients was 30 +/- 4.9 years and 27.1 +/- 3.7 years in controls </plain></SENT>
<SENT sid="9" pm="."><plain>High PRL levels were found during the second and third trimester in SLE patients in comparison with controls (186.2 +/- 54.02 ng/mL versus 119.6 +/- 31.1 ng/mL (P &lt; 0.01) and 177.4 +/- 48.6 ng/mL versus 158.3 +/- 31.5 ng/mL </plain></SENT>
<SENT sid="10" pm="."><plain>A significant linear correlation between PRL, m-SLAM, and LA in association with poor maternal-fetal outcome was observed </plain></SENT>
<SENT sid="11" pm="."><plain>LA and PRL conferred risk for poor pregnancy outcome </plain></SENT>
<SENT sid="12" pm="."><plain>Our study indicates for the first time a strong association among PRL, LA, SLE activity, and poor pregnancy outcome </plain></SENT>
<SENT sid="13" pm="."><plain>Close rheumatologic and obstetric monitoring is mandatory in SLE pregnancy in order to avoid obstetric complications </plain></SENT>
</text></document>